Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination
- PMID: 38546906
- PMCID: PMC11300578
- DOI: 10.1007/s10555-024-10169-8
Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination
Abstract
Epithelial ovarian cancer (EOC) is often diagnosed in advanced stage with peritoneal dissemination. Recent studies indicate that aberrant accumulation of collagen fibers in tumor stroma has a variety of effects on tumor progression. We refer to remodeled fibrous stroma with altered expression of collagen molecules, increased stiffness, and highly oriented collagen fibers as tumor-associated fibrosis (TAF). TAF contributes to EOC cell invasion and metastasis in the intraperitoneal cavity. However, an understanding of molecular events involved is only just beginning to emerge. Further development in this field will lead to new strategies to treat EOC. In this review, we focus on the recent findings on how the TAF contributes to EOC malignancy. Furthermore, we will review the recent initiatives and future therapeutic strategies for targeting TAF in EOC.
Keywords: Extracellular matrix; Fibrosis; Mesothelial; Metastasis; Ovarian cancer.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.Oncogene. 2017 Oct 19;36(42):5840-5851. doi: 10.1038/onc.2017.171. Epub 2017 Jun 19. Oncogene. 2017. PMID: 28628116 Free PMC article.
-
Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.Int J Cancer. 2008 Jan 1;122(1):91-9. doi: 10.1002/ijc.23083. Int J Cancer. 2008. PMID: 17893878
-
AEG -1 overexpression: a novel indicator for peritoneal dissemination and lymph node metastasis in epithelial ovarian cancers.Int J Gynecol Cancer. 2011 May;21(4):602-8. doi: 10.1097/IGC.0b013e3182145561. Int J Gynecol Cancer. 2011. PMID: 21543927
-
The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression.Cancer Metastasis Rev. 2013 Dec;32(3-4):535-51. doi: 10.1007/s10555-013-9423-y. Cancer Metastasis Rev. 2013. PMID: 23609751 Review.
-
Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles.Cell Oncol (Dordr). 2020 Aug;43(4):515-538. doi: 10.1007/s13402-020-00513-9. Epub 2020 May 16. Cell Oncol (Dordr). 2020. PMID: 32418122 Review.
References
-
- Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians,71(3), 209–249. 10.3322/caac.21660 10.3322/caac.21660 - DOI - PubMed
-
- Buy, J. N., Moss, A. A., Ghossain, M. A., Sciot, C., Malbec, L., Vadrot, D., … Decroix, Y. (1988). Peritoneal implants from ovarian tumors: CT findings. Radiology, 169(3), 691–694. 10.1148/radiology.169.3.3186993 - PubMed
-
- Arie, A. B., McNally, L., Kapp, D. S., & Teng, N. N. H. (2013). The omentum and omentectomy in epithelial ovarian cancer: A reappraisal: Part II—The role of omentectomy in the staging and treatment of apparent early stage epithelial ovarian cancer. Gynecologic oncology,131(3), 784–790. 10.1016/j.ygyno.2013.09.013 10.1016/j.ygyno.2013.09.013 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical